Back
Sarepta Therapeutics Vs. Amgen Industry Stock Comparison
Sell
43
SRPT
Sarepta Therapeutics
Last Price:
128.17
Seasonality Move:
2.77%
Buy
57
AMGN
Amgen
Last Price:
312.41
Seasonality Move:
6.64%
Sell
43
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $129.12. The Score for SRPT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Amgen (AMGN)
is a Buy
Is Amgen a Buy, Sell or Hold?
- The current Amgen [AMGN] share price is $314.85. The Score for AMGN is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- AMGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $129.12
The current trend is moderately bearish and SRPT is experiencing slight selling pressure.
AMGN Stock Price Chart
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.61 | Buy |
| Relative Strength Index (14 RSI): | 49.39 | Sell |
| Chaikin Money Flow: | -104035 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (121.93 - 134.35) | Buy |
| Bollinger Bands (100): | (114.3 - 133.04) | Buy |
AMGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 10.66 | Buy |
| Relative Strength Index (14 RSI): | 66.74 | Buy |
| Chaikin Money Flow: | 403668 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (271.8 - 311.94) | Buy |
| Bollinger Bands (100): | (272.28 - 307.14) | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 131.59 | Sell |
| 20-day SMA: | 130.98 | Sell |
| 50-day SMA: | 126.66 | Buy |
| 200-day SMA: | 113.75 | Buy |
| 8-day EMA: | 131.18 | Sell |
| 20-day EMA: | 130.09 | Sell |
| 50-day EMA: | 127.15 | Buy |
| 200-day EMA: | 118.47 | Buy |
AMGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 313.2 | Buy |
| 20-day SMA: | 297.78 | Buy |
| 50-day SMA: | 282.76 | Buy |
| 200-day SMA: | 278.75 | Buy |
| 8-day EMA: | 311.8 | Buy |
| 20-day EMA: | 301.22 | Buy |
| 50-day EMA: | 290.25 | Buy |
| 200-day EMA: | 277.26 | Buy |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.06 per share, an increase next quarter of $1.31 per share, an increase this year of $6.16 per share, and an increase next year of $6.09 per share.
Amgen Earnings Growth & AMGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.47 per share, an increase next quarter of $0.23 per share, an increase this year of $0.93 per share, and an increase next year of $1.15 per share.
Sarepta Therapeutics Technical Analysis
| May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amgen Technical Analysis
| May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||